Human epidemiological studies suggest that 1,25(OH) 2 D 3 deficiency might increase cancer incidence, but no spontaneous tumors have been reported in mice lacking 1,25(OH) 2 D 3 or deficient in its receptor. In our study, we detected, for the first time, diverse types of spontaneous tumors in l,25(OH) 2 D 3 deficient mice more than 1 year of age. This was associated with increased oxidative stress, cellular senescence and senescence-associated secretory phenotype molecules, such as hepatocyte growth factor, mediated via its receptor c-Met. Furthermore, 1,25(OH) 2 D 3 prevented spontaneous tumor development. We also demonstrated that l,25(OH) 2 D 3 deficiency accelerates allograft tumor initiation and growth by increasing oxidative stress and DNA damage, activating oncogenes, inactivating tumor suppressor genes, stimulating malignant cell proliferation and inhibiting their senescence; in contrast, supplementation with exogenous l,25(OH) 2 D 3 or antioxidant, or knock-down of the Bmi1 or c-Met oncogene, largely rescued the phenotypes of allograft tumors. Results from our study suggest that 1,25(OH) 2 D 3 deficiency enhances tumorigenesis by increasing malignant cell oxidative stress and DNA damage, stimulating microenvironmental cell senescence and a senescence-associated secretory phenotype, and activating oncogenes and inactivating tumor suppressor genes, thus increasing malignant cell proliferation. Our study provides direct evidence supporting the role of vitamin D deficiency in increasing cancer incidence. Conversely, 1,25(OH) 2 D 3 prevented spontaneous tumor development, suggesting that this inhibitory effect prevents the initiation and progression of tumorigenesis, thus provides a mechanistic basis for 1,25(OH) 2 D 3 to prevent tumorigenesis in an aging organism.
Introduction
Accumulating evidence from preclinical and epidemiologic data in human patients 1 strongly suggests that vitamin D plays a role in reducing cancer incidence. Assuring vitamin D sufficiency might thus be an economical and safe way to prevent cancer and improve the prognosis and outcome. 2 However, there are no randomized control trials providing conclusive support for a beneficial role of vitamin D supplementation. 3 Moreover, although it has been reported that vitamin D receptor (VDR) deficient mice are more susceptible to the development of carcinogen-induced cancers, 4 5, 6 or in mice with VDR gene deletion.
Despite the association with aging, senescence mechanisms may limit tumor progression, and determine the outcome of conventional anticancer therapies. Thus, it has been reported that the growth arrest of senescence is established and maintained by the p53-p21 and p16-pRb tumor suppressor pathways, 16 and therapeutic approaches such as p53 reactivation, inhibition of c-MYC or treatment with cyclindependent kinase (CDK) inhibitors have proven effective for cancer treatment by invoking a senescence response. 17 In contrast, however, senescent cells in the tumor microenvironment can exert deleterious actions. The most significant of these is the acquisition of a senescence-associated secretory phenotype (SASP) that has many of the effects one would expect from a pro-inflammatory stimulus, including the promotion of proliferation and tumorigenesis. 18 It is currently unclear whether l,25(OH) 2 D 3 can convert cells into a senescent state and whether senescent tissue cells induced by l,25(OH) 2 D 3 deficiency can stimulate tumor development by SASP molecules. Oxidative stress is also an important factor in both tumor development and responses to anticancer therapies. Many signaling pathways that are linked to tumorigenesis can also regulate the metabolism of reactive oxygen species (ROS). 19 The close link between oxidative stress and cancer is also evident in mice with targeted deletion of the redox-sensitive transcription factor, nuclear factor-erythroid-2-related factor 2 (Nrf2), which display an increase in tumorigenesis that results from a decline in antioxidative pathways. 20, 21 l,25(OH) 2 D 3 regulates expression of Nrf2 that controls many antioxidant and detoxifying enzymes. 22 In clinical trials, vitamin D supplementation reduced 8-hydroxy-2 0 -deoxyguanosine, a marker of oxidative damage, in colorectal epithelial crypt cells, 23 lymphocytes and pulmonary carcinoma cells. 24 Vitamin D deficiency may therefore contribute to cancer development through increases in redox signaling. 20, 21 In our study, we examined spontaneous tumor formation rates in mice with targeted deletion of the 1a(OH)ase and in their wild-type (WT) littermates and compared the growth of TM40D mammary tumor cells allografted into these mice. We assessed whether l,25(OH) 2 D 3 deficiency can stimulate tumor initiation and growth by increasing oxidative stress and DNA damage, altering senescence processes, activating oncogenes and inactivating tumor suppressive genes. The results provide direct evidence supporting that vitamin D deficiency increases cancer incidence.
Materials and Methods

Animals and treatments
The 1a(OH)ase 2/2 mice were generated and characterized as previously described by Panda et al. 6 One hundred and and wild-type littermates of each group were used for transplantation tumor experiments, 25 pairs of each group were maintained until death or until 600 days of age and were used for monitoring spontaneous tumor formation. In addition, 52 pairs gender-matched 1a(OH)ase 1/2 and wild-type littermates on the normal diet were used for monitoring spontaneous tumor formation. All animal experiments were carried out in compliance with, and approval by, the Animal Care and Use Committee of Nanjing Medical University.
Transplanted tumor experiments
TM40D mammary tumor cells were derived from the FSK4 mammary epithelial cell line established in vitro from normal mouse mammary gland 25, 26 (Provided by Professor Ming Zhang, Baylor College of Medicine). 2 3 10 6 TM40D cells were injected subcutaneously to the left 4-5 intercostal spatia of each mouse on different dietary/supplement regimens. After 2 weeks, the number of tumors in transplanted mice was counted and tumor volumes were measured.
Sample harvest
The age-and gender-matched wild-type and 1a(OH)ase
mice on different regimens were anesthetized. Blood was collected from heart and serum was obtained for biochemical 
Histopathology
Spontaneous tumors and their adjacent tissues, and transplanted tumors were removed and fixed in PLP fixative (2% paraformaldehyde containing 0.075 M lysine and 0.01 M sodium periodate) overnight at 48C and processed histologically as we previously described. 15 Afterwards, tissues were dehydrated and embedded in paraffin, after which 5-lm sections were cut on a rotary microtome. The tumor sections were stained with H&E and were stained immunohistochemically as described below and biochemically for senescence-associatedb-galactosidase (SA-b-gal) as previously described. 27 
Immunohistochemistry
Immunohistochemical staining was carried out for Ki-67, phosphorylation of histone H2AX on Ser139 (g-H2AX), SOD2, 8-hydroxy-2 0 -deoxyguanosine (8-OHdG) and C-met using the avidin-biotin-peroxidase complex technique with affinity-purified antibodies of Ki-67 (Abcam, Cambridge, MA, USA), g-H2AX (Cell Signaling Technology), SOD2 (Novus Biological), 8-OHdG (Novus Biological), c-Met (Cell Signaling Technology) as we previously described. 28 
Plasmids and lentiviral transfection
A modified lentiviral plasmid pCDH (mpCDH), which has both green fluorescent protein (GFP) and red fluorescent protein (RFP) cassettes, was generated based on lentiviral plasmid pCDH-CMV-MCS-EF1-copGFP (System Bioscience, Palo Alto, CA), and used as the short hairpin RNA (shRNA) expressing lentiviral vector. The short hairpin RNA (shRNA) complementary sequences to Bmi1 and c-Met are listed in Supporting Information Table S1 . To obtain the recombinant lentivirus, the HEK 293 T cells were seeded in 10 cm plates in DMEM with 10% FBS for 24 hr, and then co-transfected with lentiviral plasmids mpCDH, packaging vector psPAX2 and envelope vector pMD2.G by using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. The supernatants containing lentivirus were collected 48 hr after transfection. After lentiviral transfection, almost 100% of TM40D were positive for GFP and RFP (Supporting Information Fig. S1 ), and used for further analysis. TM40D transduced with lentivirus-Bmi1 and lentivirus-cMet are shown as sh-Bmi1 and sh-c-Met, respectively. TM40D transduced with lentivirus empty vector (mpCDH) was shown as sh-control. The plasmids aforementioned were kindly provided by Dr. Lu Chun (Department of Microbiology and Immunology, Nanjing Medical University, China).
Western blot
Proteins were extracted from the spontaneous tumors and their adjacent tissues, and from transplanted tumors. Immunoblotting was carried out as previously described [27] . Primary antibodies against 1a(OH)ase ( 
RNA isolation and real-time RT-PCR
RNA was isolated from TM40D cells using Trizol reagent (Invitrogen) according to the manufacturer's protocol. The mRNA levels of 1a(OH)ase and VDR were quantified by real-time RT-PCR as we previous described. 15 
Serum protein chip assay
Serum was separated from peripheral blood of 10-month-old sex-matched wild-type and 1a(OH)ase 2/2 mice on the normal diet. Serum protein arrays were performed using Biotin Label-based Mouse Antibody Array I (Raybiotech, Norcross, GA, USA) according to the manufacturer's instructions as described previously 29 as we previous described. 29 
Enzyme-linked immunosorbent assay
Mouse serum hepatocyte growth factor (HGF) levels were assayed by enzyme-linked immunosorbent assay with mouse HGF immunoassay kit (R&D Systems) following the manufacturer's instructions. 
Cell cultures and in vitro experiments
Analysis of cell viability (MTT assay)
TM40D cells were incubated in the presence or absence of 5-100 ng/ml HGF (hepatocyte growth factor) for 24-96 hr. After the exposure period, the medium was removed and followed by washing of the cells with PBS. Then, the medium was changed and incubated with MTT solution (5 mg/ml/ well) for 4 hr. The medium was removed and formazan was solubilized in isopropanol and measured spectrophotometrically at 563 nm. The percentage of viable cells was estimated by comparing to the untreated control cells.
Intracellular ROS analysis
For analysis of intracellular ROS, freshly isolated cells from transplanted tumors were incubated with 5 mM diacetyldichlorofluorescein (DCFDA) (Invitrogen) and placed in a shaker at 378C for 30 min, followed immediately by flow cytometry analysis in a FACS calibur flow cytometer (Becton Dickinson, Heidelberg, Germany).
Statistical analysis
All analyses were performed using SPSS software (Version 16.0, SPSS, Inc., Chicago, IL). Measured data were described as mean 6 SEM fold change over control and analyzed by Student's t-test or one-way ANOVA to compare differences between groups. Qualitative data were described as percentages and analyzed using a v 2 test as indicated. p-Values were two-sided, and <0.05 was considered statistically significant.
Results
Effect of 1,25(OH) 2 D 3 deficiency on spontaneous tumor formation
We examined the following mice for spontaneous tumor formation: heterozygous mice with targeted deletion of the Cyp27b1/1a-hydroxylase [1a (OH) 2/2 mice on a rescue diet supplemented with the antioxidant NAC (N-acetyl-L-cysteine) in drinking water. When a tumor was suspected on autopsy, histopathology was performed to confirm the diagnosis (Fig. 1a) . Spontaneous tumors were found in 6 of 52 1a(OH)ase
mice on a normal diet between 13 and 20 months of age at which time serum 1,25(OH) 2 D 3 levels were significantly reduced (Supporting Information Figs. S2a-S2c); this demonstrated a spontaneous tumor formation rate of 11.5%; no spontaneous tumors were found in 52 wild-type littermates of comparable age (Supporting Information Fig. S3a ). We found no spontaneous tumors in 50 1a(OH)ase 2/2 mice on a normal diet (rate of 0%), however 1a(OH)ase 2/2 mice on a normal diet survived for only 67-120 days. When 1a(OH)ase 2/2 mice were fed a rescue diet, survival was increased to between 154 and 465 days. Among 21 1a(OH)ase 2/2 mice that survived over 12 months, spontaneous tumors were found in 5 1a(OH)ase 2/2 mice, demonstrating a spontaneous tumor formation rate of 23.8%. Subcutaneous administration of 1,25(OH) 2 D 3 or a rescue diet combined with NAC not only prolonged the lifespan of 1a(OH)ase 2/2 mice to 358-540 days and 320-540 days, respectively, but also prevented spontaneous tumor formation (Supporting Information Fig. S3a ). The pathological diagnosis of the 11 spontaneous tumors included breast cancer (1), squamous-cell carcinoma of skin (1), soft tissue sarcoma (1), hepatocellular carcinoma (1), granulocytic sarcoma (1), endometrial stromal tumor (1), gastrointestinal stromal tumor (1) and pulmonary adenocarcinoma (4) (Supporting Information Table S2 ). These results demonstrated that 1,25(OH) 2 D 3 deficiency could increase diverse types of spontaneous tumor formation, and these could be prevented with exogenous 1,25(OH) 2 D 3 or antioxidant NAC, but not by only normalizing serum calcium and phosphate.
Cells immunopositive for the antioxidant enzyme SOD2 were reduced in spontaneous tumor tissue compared to the paracancerous tissue (Fig. 1b) , In addition, the percentage of cells positive for the DNA damage marker, phosphorylation of histone protein H2AX (g-H2AX) and for the cell proliferation marker, Ki67, were increased significantly in spontaneous tumor tissue compared to the paracancerous tissue (Figs. 1c and 1d); in contrast, the senescence-associated b-galactosidase (SA-b-gal) positive cells were not detected in the normal lung and intestine tissue; however, these cells were found in paracancerous tissue derived from 1a(OH)ase 2/2 mice, but not in spontaneous tumor tissues (Supporting Information  Fig. S3b) . Furthermore, protein expression levels of the C-fos and Ras oncogenes and of Bmi1 (B lymphoma Mo-MLV insertion region 1), a member of the polycomb family of oncogenes, were downregulated, whereas protein expression levels of the tumor suppressor genes p16, p21 and p27 were upregulated in 1,25(OH) 2 D deficient tissues compared to 1,25(OH) 2 D sufficient tissues (Fig. 2a) . In contrast, protein expression levels of the C-fos, Ras and of Bmi1 were upregulated, whereas protein expression levels of p16, p21 and p27 were downregulated in spontaneous tumor tissue compared to the paracancerous tissue, even compared to corresponding normal tissues of 1,25(OH) 2 D sufficient mice (Fig. 2a) . Although we cannot say whether the changes in protein levels in the spontaneous tumors temporally preceded tumor formation or occurred subsequent to tumor formation in the 1,25(OH) 2 D-deficient animals, the pattern of increase in the oncogenic proteins and of decrease in the tumor suppressors relative to levels in the normal tissues of 1,25(OH) 2 D sufficient mice, which was consistent with their known function in contributing to tumor growth, suggested that they contributed to tumorigenesis in the 1,25(OH) 2 D-deficient mice. We also found, by immunohistochemistry, that expression levels of c-Met, the receptor for hepatocyte growth factor (HGF) were higher in 5 out of 5 spontaneous tumors than in paracancerous tissue in 1,25(OH) 2 D 3 deficient mice (Fig. 2b) . These results suggest that l,25(OH) 2 D 3 deficiency increased spontaneous tumors by stimulating cell proliferation through increased oxidative stress and DNA damage, activating oncogenes and inhibiting tumor suppressor genes.
Effect of 1,25(OH) 2 D 3 deficiency on the senescence-associated secretory phenotype (SASP)
To assess whether 1,25(OH) 2 D 3 deficiency resulted in an alteration of the senescence-associated secretory phenotype (SASP), subsequently stimulated tumor growth, the protein expression profile of serum from 10-month-old 1a(OH)ase 2/2 mice and their wild-type littermates on the rescue diet was analyzed using a protein array approach. Cluster analysis was performed (Fig. 2c ) and 13 SASP constituents were detected which were >2-fold upor downregulated in serum from 10-month-old 1a(OH)ase
mice on a rescue diet compared to serum levels in WT mice (Supporting Information Fig. S3c and Table S3 ). Seven proteins including tumor necrosis factor receptor superfamily member 13C protein (BAFF R/TNFRSF13C), fibroblast growth factor 21 (FGF21), HGF, interleukin-1 receptor 9 (IL-1 R9), IL-5 receptor a, IL-6 and monocyte chemotactic proteins-5 (MCP-5) were upregulated, and 6 proteins including angiopoietin-like 3, insulin-like growth factor binding protein 7 (IGFBP-7), IL-2 receptor b, the receptor tyrosine kinase Tie2, thyroid peroxidase (TPO) and vascular endothelial growth factor D (VEGF-D) were downregulated. In view of the fact that HGF levels were highest in the protein array and that the HGF/c-Met signaling axis plays an important role in tumorigenesis, we confirmed by ELISA that serum HGF levels were markedly higher in 1a(OH)ase 2/2 mice on the rescue diet than in their WT littermates (Fig. 2f) . Furthermore, HGF stimulated the growth of mouse-derived breast cancer cells (TM40D) in culture in both a time-and dose-dependent manner (Fig. 2g) . These results indicate that 1,25(OH) 2 D 3 deficiency-induced SASP molecules, especially HGF, play an important role in tumorigenesis.
To further determine whether increased HGF caused by 1,25(OH) 2 D 3 deficiency stimulated tumor growth via c-Met, we created a stably c-Met silenced TM40D cell line (Fig. 2f) . The cell growth of the TM40D cells was not altered significantly by knock-down of c-Met itself, but growth of the TM40D cells stimulated by HGF treatment was blocked by knock-down of cMet (Figs. 2g-i) . In vivo, volumes of transplanted tumors were slightly, but not significantly, reduced in WT mice by knock- (Figs. 3e-3g ). Levels of ROS ( (Figs. 6a and 6b ). When they were transplanted to nude mice, tumor volumes were decreased significantly in the transplanted tumors from TM40D-shBmi1 cells compared to those from TM40D-vector cells (Figs. 6c and  6d ). Bmi1 expression levels were downregulated, whereas p16, p19 and p53 expression levels were upregulated in the transplanted tumors from TM40D-shBmi1 cells compared to those from TM40D-vector cells (Fig. 6e) . When TM40D-shBmi1 cells were transplanted to 1a(OH)ase 2/2 mice, tumor volumes and tumor cell proliferation were markedly decreased (Figs. 6f-6i ) and the cell senescence marker SA-b-Gal was increased significantly (Figs. 6j and 6k) compared to those from TM40D-vector cells. These results suggest that the upregulation of Bmi1 caused by 1,25(OH) 2 D 3 deficiency plays a critical role in accelerating tumor growth by stimulating tumor cell proliferation and inhibiting their senescence mediated via inactivating p16/ Rb and p19/p53 signaling pathways. 30 
Discussion
We used mice with 1a-hydroxylase deletion and wild-type littermates for our experiments. The only genetic difference between these two animals was the deficiency of cyp27b1 encoding the 1a(OH)ase enzyme. Furthermore, these mice Each value is the mean 6 SEM of determinations in 5 mice of each group.*p < 0.05; **p < 0.01; ***p < 0.001 compared to WT mice. ##p < 0.01 compared to 1a(OH)ase 2/2 mice on a normal diet (ND KO) mice. &&p < 0.01 compared to 1a(OH)ase 2/2 mice on a rescue diet (RD KO mice).
were exposed, for comparison, to the same environment including diet. Prospectively the 1a(OH)ase 2/2 group developed tumors spontaneously whereas the control group did not and such tumors could be prevented by treating with 1,25(OH) 2 Each value is the mean 6 SEM of determinations in 5 mice of each group.*p < 0.05; **p < 0.01; ***p < 0.001compared to WT mice. #p < 0.05; ##p < 0.01 compared to ND KO mice. &p < 0.05; &&p < 0.01 compared to RD KO mice.
We then searched for plausible mechanisms of tumor formation in one group vs. the other. We found that spontaneous tumors could only be detected in mice with 1a-hydroxylase deletion that were older than 1 year of age, suggesting that increased cancer incidence caused by 1,25(OH) 2 D 3 deficiency is linked with aging. Age is the strongest demographic risk factor for most human malignancies 31 and aging is involved in a number of events responsible for carcinogenesis and cancer development at the molecular, cellular and tissue levels. 10, 32 Thus, accumulating evidence shows that aging-induced senescent cells secrete molecules that can stimulate premalignant cells to proliferate and form tumors. 33 We therefore compared the protein expression profiles of serum from 10-month-old l,25(OH) 2 D 3 deficient mice on a rescue diet, and from their WT littermates to identify molecules secreted by senescent tissue cells induced by l,25(OH) 2 D 3 deficiency. We found that seven proteins were upregulated significantly including HGF. HGF is released by many cell types in the tumor microenvironment and can target its receptor c-MET within the cells of primary tumors. 34 Indeed, we found that c-Met expression levels in the spontaneous tumors of 1,25(OH) 2 D 3 deficient mice were clearly higher than in the paracancerous tissues. We then demonstrated that HGF can stimulate the growth of mouse-derived breast cancer cells (TM40D) in cultures in both time-and dose-dependent manners, and cell growth of the TM40D cells stimulated by HGF treatment was blocked by knock-down of c-Met (Figs. 2g-2i ). In vivo, increased tumor volumes in 1,25(OH) 2 D-deficient 1a(OH)ase 2/2 mice which had increased HGF, were markedly reduced by knockdown of c-Met (Figs. 2j and 2k ). Consequently increased HGF induced by 1,25(OH) 2 D deficiency accelerates tumor growth via its receptor c-Met. Although we have not formally shown that the increase in HGF caused by the 1,25(OH) 2 D deficiency contributed to spontaneous tumor formation in our animals, we have nevertheless shown that HGF does stimulate the growth of the TM40D cells via c-Met. Furthermore, there is evidence in the literature that elevated HGF stimulates mitogenesis and tumorogenesis, 35 and in vitro evidence that 1,25(OH) 2 D inhibits the growth of a hepatic cell line, by downregulating c-Met. 36 Targeting HGF/c-MET signaling has provided a valuable tool for the treatment of several malignancies and for overcoming drug resistance in cancer therapy. 37 Our results therefore suggest that increased spontaneous tumor incidence caused by 1,25(OH) 2 D 3 deficiency was associated with aging-induced cell senescence and SASP molecule production by cells in the tumor microenvironment, especially HGF, in association with increased expression of its receptor c-Met. Paradoxically, senescence may have diverse effects that include not only tumorigenic effects but also tumor suppressive effects. Thus, although l,25(OH) 2 D 3 deficiency stimulated senescence and SASP in paracancerous cells adjacent to spontaneous tumors, it also inhibited senescence in tumor cells (Fig. 5) , Senescence may be an essential tumor suppressive barrier to counteract tumor progression in vivo. Pre-clinical evidence demonstrates that senescence enhancement in tumors, also called "pro-senescence therapy" for cancer, e.g. in response to radiotherapy or selected chemotherapy agents, is effective in promoting tumor regression. 38 The mechanisms that mediate TIS in cancer cells are not well defined. Primary murine lymphomas have been shown to respond to cyclophosphamide therapy by engaging a senescence program controlled by p53 and p16 INK4a . 39 Several independent stimuli including replicative senescence, oncogene-induced senescence (OIS) and cellular senescence (PICS) induced by loss of the phosphatase and tensin (PTEN) protein, have the capacity to induce senescence; through various common key effector pathways such as p19-p53-p21, p16-Rb or p27 pathways. 38 In our studies, in l,25(OH) 2 D 3 -deficient mice, expression levels of the tumor suppressors p21, p16 and p27 were downregulated in spontaneous tumor tissues with reduced senescence, compared to adjacent paracancerous tissues. In contrast, the protein expression levels of DNA damage marker 8-OHdG or g-H2AX and of the oncogenes Bmi1 and Ras were upregulated. Although we did not formally examine alteration in cell proliferation in our studies, there is abundant evidence in the literature that changes in these tumor suppressor genes and oncogenes modify cell proliferation. [40] [41] [42] We also found that normal physiological l,25(OH) 2 D 3 levels in WT mice can induce senescence in allograft breast cancer cells, whereas l,25(OH) 2 D 3 deficiency can suppress senescence and reduce protein expression levels of the tumor suppressors as well as increase levels of the DNA damage markers and oncogenes. Administration of exogenous l,25(OH) 2 D 3 to l,25(OH) 2 D 3 deficient mice, again induced breast cancer cells into senescence, upregulating p21, p16 and Protein levels relative to bactin protein levels were assessed by densitometric analysis and expressed as percentage of the levels in transplanted tumors of vehicletreated wild-type mice fed a normal diet (ND). Relative protein expression levels of (i) Bmi-1, (j) Ras, (k) p16, (l) p21 and (m) p27 in transplanted tumors. Each value is the mean 6 SEM of determinations in 5 mice of each group.*p < 0.05; **p < 0.01; ***p < 0.001 compared to WT mice. #p < 0.05; ##p < 0.01; ###p < 0.001 compared to ND KO mice. &p < 0.05; &&p < 0.01; &&&p < 0.001 compared to RD KO mice. p27 and downregulating DNA damage markers and oncogenes including Bmi1.
The Bmi1 oncogene is a transcriptional repressor, 43 which is overexpressed in various human cancer tissues and is known to be involved in cancer cell proliferation, cell invasion, distant metastasis, chemoresistance and reduced patient survival. 44 Its oncogenic function has mainly been attributed to its repressive effect on the Ink4a/Arf tumor suppressor locus. 45 Bmi1 protein levels were upregulated in both the spontaneous and allograft tumors in the absence of 1,25(OH) 2 that genetic Bmi1 silencing and pharmacological inhibition of Bmi1 significantly impaired tumor growth in a tongue cancer xenograft model 46 and in lung adenocarcinomas. 47 Our results therefore indicate that 1,25(OH) 2 D 3 prevents tumorigenesis by inactivating oncogenes such as Bmi1 which appear to play a key role in tumorigenesis.
Our study also demonstrates the role of l,25(OH) 2 D 3 in preventing tumorigenesis through inhibiting oxidative stress and DNA damage. We found that the expression levels of antioxidant enzyme SOD2 were reduced, whereas the expression levels of DNA damage marker g-H2AX were increased in spontaneous tumor tissues. In tumor allograft experiments, we demonstrated that levels of ROS and the expression levels of DNA damage marker 8-OHdG were increased, whereas protein expression levels of antioxidant enzymes, Prdx I and IV and SOD2 were reduced in tumors transplanted into1-a(OH)ase deficient mice. These parameters were largely normalized by supplementation with exogenous l,25(OH) 2 D 3 . Previous studies demonstrated that vitamin D is a very effective antioxidant, with a capacity to inhibit zinc-induced oxidative stress in the central nervous system which is 10 3 times that of vitamin E analogs, 48 and showed that a vitamin D analog exerts antioxidant effects by activating the Nrf2-Keap1 antioxidant pathway. 49 Clinical trials of vitamin D supplementation in colorectal cancer 23 and in pulmonary carcinoma 24 have suggested that vitamin D protects against DNA damage in humans in vivo. Our in vivo data also demonstrated that as with exogenous l,25(OH) 2 D 3 administration, supplementation of the antioxidant NAC can also prevent spontaneous tumor development. Nevertheless, it remains unclear whether dietary antioxidant supplements are beneficial in primary cancer prevention or treatment in humans. 50 Therefore, our results suggest that l,25(OH) 2 D 3 , may exert a preventive role against various cancers, at least in mice, in part through its effective antioxidant function.
In our study, we report, for the first time, diverse types of spontaneous tumors occurring in aged 1,25(OH) 2 Overall therefore the results of our study provide a model that suggests that 1,25(OH) 2 D 3 deficiency results in increasing oxidative stress and DNA damage, thus accelerating aging, associated with increased cellular senescence in the tumor microenvironment and senescence-associated secretory phenotype, especially increased hepatocyte growth factor release. 1,25(OH) 2 D 3 deficiency may also stimulating tumorigenesis though activation of oncogenes, especially c-Met and Bmi1 and Bmi1, by inhibiting CDKI, may inhibit tumor cell senescence (Fig. 6l) . Our study therefore provides a mechanistic basis for 1,25(OH) 2 D 3 to prevent tumorigenesis in an aging organism.
